City

Condition

B Precursor Acute Lymphoblastic Leukemia (1)

Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Amgen (1)

Collaborator

Intervention

blinatumomab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

b precursor acute lymphoblastic leukemia

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia Trial (Blinatumomab)

Not yet recruiting

B Precursor Acute Lymphoblastic Leukemia
Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia

Blinatumomab

(no location specified)

Sep 25, 2023